BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35214688)

  • 1. Immunogenicity of Multi-Target Chimeric RHDV Virus-Like Particles Delivering Foreign B-Cell Epitopes.
    Zamora-Ceballos M; Moreno N; Gil-Cantero D; Castón JR; Blanco E; Bárcena J
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric RHDV Virus-Like Particles Displaying Foot-and-Mouth Disease Virus Epitopes Elicit Neutralizing Antibodies and Confer Partial Protection in Pigs.
    Rangel G; Bárcena J; Moreno N; Mata CP; Castón JR; Alejo A; Blanco E
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34066934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabbit hemorrhagic disease virus capsid, a versatile platform for foreign B-cell epitope display inducing protective humoral immune responses.
    Moreno N; Mena I; Angulo I; Gómez Y; Crisci E; Montoya M; Castón JR; Blanco E; Bárcena J
    Sci Rep; 2016 Aug; 6():31844. PubMed ID: 27549017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric calicivirus-like particles elicit specific immune responses in pigs.
    Crisci E; Fraile L; Moreno N; Blanco E; Cabezón R; Costa C; Mussá T; Baratelli M; Martinez-Orellana P; Ganges L; Martínez J; Bárcena J; Montoya M
    Vaccine; 2012 Mar; 30(14):2427-39. PubMed ID: 22306796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric VLPs Bearing VP60 from Two Serotypes of
    Dalton KP; Alvarado C; Reytor E; Del Carmen Nuñez M; Podadera A; Martínez-Alonso D; Alonso JMM; Nicieza I; Gómez-Sebastián S; Dalton RM; Parra F; Escribano JM
    Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and immunogenicity of novel bivalent virus-like particles bearing VP60 genes of classic RHDV(GI.1) and RHDV2(GI.2).
    Qi R; Miao Q; Zhu J; Tang J; Tang A; Wang X; Dong D; Guo H; Liu G
    Vet Microbiol; 2020 Jan; 240():108529. PubMed ID: 31902498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antigenic and immunogenic activity of virus-like particles based on rabbit hemorrhagic disease virus (Caliciviridae:
    Mukhin AN; Alekseev KP; Yuzhakov AG; Selezneva EV; Moskvinа AS; Verkhovsky OA; Aliper TI
    Vopr Virusol; 2023 May; 68(2):132-141. PubMed ID: 37264848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant.
    Crisci E; Almanza H; Mena I; Córdoba L; Gómez-Casado E; Castón JR; Fraile L; Bárcena J; Montoya M
    Virology; 2009 May; 387(2):303-12. PubMed ID: 19327809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
    Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y
    Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of different recombinant rabbit hemorrhagic disease virus-like particles carrying CD8+ T cell epitope from chicken ovalbumin (OVA).
    Chen M; Song Y; Fan Z; Jiang P; Hu B; Xue J; Wei H; Wang F
    Virus Res; 2014 Apr; 183():15-22. PubMed ID: 24457072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembly of virus-like particles of rabbit hemorrhagic disease virus capsid protein expressed in Escherichia coli and their immunogenicity in rabbits.
    Guo H; Zhu J; Tan Y; Li C; Chen Z; Sun S; Liu G
    Antiviral Res; 2016 Jul; 131():85-91. PubMed ID: 27118636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
    Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
    Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
    Wei S; Lei Y; Yang J; Wang X; Shu F; Wei X; Lin F; Li B; Cui Y; Zhang H; Wei S
    Vaccine; 2018 Apr; 36(17):2273-2281. PubMed ID: 29576303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric virus-like particles for the delivery of an inserted conserved influenza A-specific CTL epitope.
    Cheong WS; Reiseger J; Turner SJ; Boyd R; Netter HJ
    Antiviral Res; 2009 Feb; 81(2):113-22. PubMed ID: 19007818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Production of Chimeric Hepatitis B Virus-Like Particles Bearing an Epitope of Hepatitis E Virus Capsid by Transient Expression in
    Zahmanova G; Mazalovska M; Takova K; Toneva V; Minkov I; Peyret H; Lomonossoff G
    Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33477348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16.
    El Mehdaoui S; Touzé A; Laurent S; Sizaret PY; Rasschaert D; Coursaget P
    J Virol; 2000 Nov; 74(22):10332-40. PubMed ID: 11044077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.